Cingulate (CING) Current Leases (2021 - 2026)
Cingulate's (CING) quarterly Current Leases came in at $238864.0 in Q4 2025, up 82.81% YoY from $130662.0 in Q4 2024, and up 3.35% on a QoQ basis from $231123.0 in Q3 2025.
Cingulate (CING) Current Leases (2021 - 2026) Analysis & Trends
Cingulate (CING) has 5 years of Current Leases data on file, last reported at $238864.0 in Q4 2025.
- Quarterly Current Leases rose 82.81% year-over-year to $238864.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $238864.0 (up 82.81% YoY) and the FY2025 annual result came in at $238864.0, up 82.81% from the prior year.
- Current Leases improved to $238864.0 in Q4 2025, from $231123.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $348499.0 in Q2 2023 to a low of $15335.0 in Q1 2022.
- A 5-year average of $142411.3 and a median of $81903.5 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases jumped 2143.4% — and 2024, when it tumbled 94.96%.
- Tracing CING's Current Leases over 5 years: stood at $295595.0 in 2021, then slumped by 94.57% to $16053.0 in 2022, then rose by 6.25% to $17057.0 in 2023, then soared by 666.03% to $130662.0 in 2024, then jumped by 82.81% to $238864.0 in 2025.
- The last three Current Leases figures came in at $238864.0 (Q4 2025), $231123.0 (Q3 2025), and $33145.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cingulate | 72.85 Mn | 72.85 Mn | - | 255,132.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 255,132.00 |
| Dec 31, 2025 | 238,864.00 |
| Sep 30, 2025 | 231,123.00 |
| Mar 31, 2025 | 33,145.00 |
| Dec 31, 2024 | 130,662.00 |
| Sep 30, 2024 | 225,368.00 |
| Jun 30, 2024 | 317,343.00 |
| Mar 31, 2024 | 17,326.00 |
| Dec 31, 2023 | 17,057.00 |
| Sep 30, 2023 | 16,805.00 |
| Jun 30, 2023 | 348,499.00 |
| Mar 31, 2023 | 344,026.00 |
| Dec 31, 2022 | 16,053.00 |
| Sep 30, 2022 | 15,810.00 |
| Jun 30, 2022 | 15,570.00 |
| Mar 31, 2022 | 15,335.00 |
| Dec 31, 2021 | 295,595.00 |